ResMed (RMD) Stock Chart & Stock Price History $284.23 +4.06 (+1.45%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$285.87 +1.64 (+0.58%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ResMed Stock Price Performance The ResMed (RMD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 31.23%, with a year-to-date return of 24.29%. In the past month, the stock has increased 11.14%, reflecting recent market activity. As of the latest close, ResMed traded at $284.23 with a market cap of $41.68 billion and volume of 827,364 shares. Five years ago, the stock traded at $173.24, representing a 64.07% increase over that period. At the time, it had a market cap of $25.12 billion and a volume of 1.26 million shares. Receive RMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.43%1 Month Performance+11.14%3 Month Performance+15.96%Year-To-Date Performance+24.29%1 Year Performance+31.23%5 Year Performance+64.07% RMD Stock Chart for Saturday, August, 9, 2025 RMD Chart by TradingView ResMed Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$279.86$284.23+1.56%$284.74$279.61827,364 shs$41.68 billion08/07/2025$280.25$279.86-0.14%$282.95$277.54929,026 shs$41.04 billion08/06/2025$284.72$280.25-1.57%$285.49$279.45985,888 shs$41.09 billion08/05/2025$291.30$284.72-2.26%$287.50$276.661.62 million shs$41.75 billion08/04/2025$278.78$291.30+4.49%$293.08$278.221.58 million shs$42.71 billion08/01/2025$272.16$278.78+2.43%$281.90$271.111.80 million shs$40.88 billion07/31/2025$277.37$272.16-1.88%$277.30$271.941.44 million shs$39.91 billion07/30/2025$278.07$277.37-0.25%$278.86$271.641.71 million shs$40.67 billion07/29/2025$273.52$278.07+1.66%$278.10$271.801.49 million shs$40.77 billion07/28/2025$275.29$273.52-0.64%$274.61$270.871.02 million shs$40.11 billion Get the Latest News and Ratings for RMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$273.43$275.29+0.68%$275.80$271.531.06 million shs$40.37 billion07/24/2025$273.18$273.43+0.09%$274.00$271.01880,777 shs$40.09 billion07/23/2025$267.90$273.18+1.97%$273.38$268.291.08 million shs$40.06 billion07/22/2025$261.10$267.90+2.60%$268.65$261.061.37 million shs$39.28 billion07/21/2025$257.64$261.10+1.34%$261.89$258.221.01 million shs$38.28 billion07/18/2025$256.37$257.64+0.49%$260.37$256.53894,150 shs$37.78 billion07/17/2025$254.00$256.37+0.93%$256.70$253.09802,122 shs$37.59 billion07/16/2025$251.98$254.00+0.80%$254.45$250.18829,576 shs$37.24 billion07/15/2025$254.09$251.98-0.83%$258.85$251.351.02 million shs$36.95 billion07/14/2025$254.15$254.09-0.02%$255.62$252.32925,026 shs$37.26 billion07/11/2025$258.09$254.15-1.53%$257.54$252.64517,805 shs$37.26 billion07/10/2025$255.75$258.09+0.92%$261.08$255.60637,776 shs$37.84 billion07/09/2025$256.71$255.75-0.37%$256.79$251.40792,474 shs$37.50 billion07/08/2025$256.16$256.71+0.21%$259.49$255.35535,223 shs$37.64 billion Related Companies Medpace Stock Chart Encompass Health Stock Chart Hims & Hers Health Stock Chart Boston Scientific Stock Chart Stryker Stock Chart Medtronic Stock Chart IDEXX Laboratories Stock Chart Becton, Dickinson and Company Stock Chart Edwards Lifesciences Stock Chart DexCom Stock Chart Receive RMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ResMed and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:RMD) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
